Price $0.08 |
Market Cap
4.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
1.03
|
Dividend %
-
|
|
P/CF
56.1
|
P/FCF
-
|
Op. Cash Flow
-200
|
FCF
0.0
|
|
Op. Margin
-13.20%
|
Net Margin
-18.90%
|
ROE
87.70%
|
ROI
-84.00%
|
|
ROA
-35.20%
|
EPS Growth
13.20%
|
Current Ratio
0.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.81 | - | - | 2.02B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $24.00 | - | - | 888.4M | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
| Aravive Inc (ARAV) | $5.45 | - | - | 129.6M | Strong Buy |
| Eyenovia Inc (EYEN) | $5.31 | - | - | 127.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
